Group One Trading, L.P. Gritstone Bio, Inc. Transaction History

Group One Trading, L.P.

$2.4 Billion
Q3 2024

A detailed history of Group One Trading, L.P. transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 108,151 shares of GRTS stock, worth $3,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares

108,151

Previous 100,451 7.67%

Holding current value

$3,244

Previous $62,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.45 - $0.71 $3,465 - $5,467	7,700 Added 7.67%	108,151 $62,000
Q2 2024 Aug 14, 2024	BUY	$0.62 - $2.35 $62,279 - $236,059	100,451 New	100,451 $62,000
Q4 2023 Feb 14, 2024	BUY	$1.28 - $2.85 $195,516 - $435,328	152,747 Added 441.76%	187,324 $382,000
Q3 2023 Nov 09, 2023	SELL	$1.19 - $2.26 $160,566 - $304,941	-134,930 Reduced 79.6%	34,577 $59,000
Q2 2023 Aug 09, 2023	SELL	$1.66 - $3.03 $29,743 - $54,291	-17,918 Reduced 9.56%	169,507 $330,000
Q1 2023 May 12, 2023	BUY	$2.13 - $3.74 $380,795 - $668,625	178,777 Added 2067.26%	187,425 $521,000
Q4 2022 Feb 09, 2023	SELL	$2.17 - $3.92 $4,693 - $8,478	-2,163 Reduced 20.01%	8,648 $29,000
Q3 2022 Nov 09, 2022	SELL	$2.46 - $4.75 $57,145 - $110,342	-23,230 Reduced 68.24%	10,811 $28,000
Q2 2022 Aug 11, 2022	SELL	$1.77 - $4.34 $10,112 - $24,794	-5,713 Reduced 14.37%	34,041 $82,000
Q1 2022 May 12, 2022	BUY	$4.03 - $12.19 $119,013 - $359,995	29,532 Added 288.91%	39,754 $164,000
Q4 2021 Feb 11, 2022	BUY	$8.76 - $13.71 $89,544 - $140,143	10,222 New	10,222 $131,000
Q3 2021 Nov 12, 2021	SELL	$6.41 - $13.54 $5,852 - $12,362	-913 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$8.13 - $10.2 $7,211 - $9,047	887 Added 3411.54%	913 $8,000
Q1 2021 May 12, 2021	BUY	$4.07 - $27.11 $105 - $704	26 New	26 $0

Others Institutions Holding GRTS

# of Institutions

Shares Held

35.4M

Call Options Held

395K

Put Options Held

132K

View Full List

About Gritstone bio, Inc.

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

More about GRTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Gritstone Bio, Inc. Transaction History